SCHEDULE 13D/AFiled Aug 26, 8:00 PM ET
Inozyme Pharma, Inc. SCHEDULE 13D/A
Pivotal bioVenture Partners Fund I, L.P.Summary not available
This filing does not have a generated research summary. You can still open the original filing and its exhibits.